Lisa Emmens

Physician-scientist

Lisa Emmens started with a pilot project in the Cardiology department in 2014 as a second-year medical student. Ever since, she never left: June 2016 she was accepted into the MD-PhD programme and in June 2020 she obtained her MD degree. In September 2021 she successfully defended her thesis entitled “Novel insights in urinary and plasma biomarkers in heart failure” and obtained her PhD degree.

Contact details

Current activities

Her postdoctoral research primarily focuses on biomarkers and risk factors in the prevention of heart failure.

My projects

BIOSTAT-CHF

Facilitate personalized therapies in patients with heart failure

My publications

Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure.

Emmens JE, Jones DJL, Cao TH, Chan DCS, Romaine SPR, Quinn PA, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, Metra M, de Boer RA, Voors AA, Ng LL. Eur J Heart Fail. 2018

view on publisher site

Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure.

Emmens JE, Ter Maaten JM, Damman K, van Veldhuisen DJ, de Boer RA, Struck J, Bergmann A, Sama IE, Streng KW, Anker SD, Dickstein K, Lang CC, Metra M, SAmani NJ, Ng LL, Voors AA. Circ Heart Fail. 2019

view on publisher site

Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome.

Emmens JE, ter Maaten JM, Matsue Y, Metra M, O’Connor CM, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Dittrich HC, Todd J, van Veldhuisen DJ, Hillege HL, Damman K, van der Meer P, Voors AA. Eur J Heart Fail. 2016

view on publisher site